| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | Chief Financial Officer
1 company
Notman Donald is a See Remarks at OCULAR THERAPEUTIX, INC. Recent SEC Form 4 filings include 3 buys and 6 sells.
Estimated insider holdings value: $3.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 2, 2025 | OCUL Ocular Therapeutix, Inc | See Remarks | Sell | 1,066 | $12.43 | $13,250.38 | -0.3% | -7.8% | - | |
| Feb 4, 2025 | OCUL Ocular Therapeutix, Inc | See Remarks | Sell | 17,420 | $7.82 | $136,239.23 | -4.2% | -1.2% | +9.3% | |
| Feb 5, 2024 | OCUL Ocular Therapeutix, Inc | Chief Financial Officer | Sell | 6,212 | $4.86 | $30,190.32 | -3.1% | +17.2% | +58.0% | |
| Jan 31, 2024 | OCUL Ocular Therapeutix, Inc | Chief Financial Officer | Sell | 6,433 | $4.95 | $31,843.35 | -4.4% | -2.5% | +60.1% | |
| Feb 6, 2023 | OCUL Ocular Therapeutix, Inc | Chief Financial Officer | Sell | 6,476 | $4.24 | $27,458.24 | -4.4% | +50.6% | +18.6% | |
| Jun 14, 2019 | OCUL Ocular Therapeutix, Inc | Chief Financial Officer | Buy | 2,500 | $4.33 | $10,825.00 | +11.6% | - | - | |
| Aug 14, 2018 | OCUL Ocular Therapeutix, Inc | Chief Financial Officer | Buy | 12,500 | $6.29 | $78,625.00 | +260.4% | - | - | |
| Dec 7, 2017 | OCUL Ocular Therapeutix, Inc | Chief Financial Officer | Buy | 4,800 | $4.00 | $19,200.00 | New | - | - |